The ROE as of September 2024 (TTM) for Greenwich LifeSciences, Inc. (GLSI) is -153.95%

According to Greenwich LifeSciences, Inc.’s latest financial reports and current stock price. The company's current ROE is -153.95%. This represents a change of 283.27% compared to the average of -40.17% of the last 4 quarters.

Greenwich LifeSciences, Inc. (GLSI) Historical ROE (quarterly & annually)

How has GLSI ROE performed in the past?

The mean historical ROE of Greenwich LifeSciences, Inc. over the last ten years is 10.69%. The current -153.95% ROE has changed -1540.34% with respect to the historical average. Over the past ten years (40 quarters), GLSI's ROE was at its highest in in the December 2019 quarter at 24.92%. The ROE was at its lowest in in the March 2024 quarter at -48.30%.

Greenwich LifeSciences, Inc. (GLSI) ROE by Quarter and Year

Discovering the peaks and valleys of Greenwich LifeSciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Greenwich LifeSciences, Inc. (GLSI) Average ROE

How has GLSI ROE performed in the past?

The current ROE of Greenwich LifeSciences, Inc. (GLSI) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Greenwich LifeSciences, Inc. (GLSI) ROE vs. Peers

How is GLSI’s ROE compared to its peers?

Greenwich LifeSciences, Inc.’s ROE is less than Reviva Pharmaceuticals Holdings, Inc. (7.96%), greater than Eyenovia, Inc. (-615.55%), greater than Immutep Limited (-42.11%), greater than Anavex Life Sciences Corp. (-30.62%), greater than Virpax Pharmaceuticals, Inc. (-1554.74%), greater than Acurx Pharmaceuticals, Inc. (-371.20%), greater than MediciNova, Inc. (-13.37%), greater than NextCure, Inc. (-57.63%), greater than Entera Bio Ltd. (-100.37%), less than X4 Pharmaceuticals, Inc. (32.93%), greater than Terns Pharmaceuticals, Inc. (-39.58%), greater than Day One Biopharmaceuticals, Inc. (-122.70%), greater than PDS Biotechnology Corporation (-137.06%), greater than Inozyme Pharma, Inc. (-68.93%), less than Amylyx Pharmaceuticals, Inc. (0%), greater than Acumen Pharmaceuticals, Inc. (-46.15%), greater than null (-24.63%),

Build a custom stock screener for Greenwich LifeSciences, Inc. (GLSI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Greenwich LifeSciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Greenwich LifeSciences, Inc. (GLSI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Greenwich LifeSciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.